Axitinib multi target TKI

AG-013736 - AG013736 - AG 013736 - Inlyta



Trial Studied treatment Control Patients Size Study type Results NCT

Renal-cell carcinoma (advanced) - multi target TKI in all type of patients

AXIS (Rini), 2011axitinibsorafenibNA NCT00678392
Qin, 2012axitinibsorafenibNA



- About - Browse pathology | treatment - Site map - Credits Made with in Lyon - Contact us - Privacy policy - Licence Creative Commons